Posts

Showing posts with the label cost-cutting

Novo Nordisk To Lay Off 9,000 Jobs as Part of Restructuring

Image
Novo Nordisk will lay off 9,000 jobs as part of a restructuring plan to reignite growth amid intense competition from the drug industry. The structuring plan is expected to save the medical company close to $1.25 billion annually. The decision to fire staff comes after the firm experienced a drop in sales due to compounded copycat drugs making their way into the markets. The copycat drugs are available at cheaper rates, which has led to a major drop in revenue. Also Read: ANZ Bank To Cut 3,500 Jobs in a Major Restructure Plan Novo Nordisk To Fire 9,000 Employees by 2026 Source: LinkedIn Its rival pharmaceutical company Eli Lilly has launched compounded copycat drugs, eating into Novo Nordisk’s revenues. In addition, Novo Nordisk is facing slowing momentum in its obesity and diabetes franchises. The firm’s first highly effective obesity drug, Wegovy, was a success in both the US and European markets. After the Coronavirus lockdowns, the medical firm ramped up its hiring spree...